Citicoline and Memory Function in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Nakazaki E, Mah E, Sanoshy K, Citrolo D, Watanabe F
Published in Journal of Nutrition
Methodology
Randomized, double-blind, placebo-controlled trial of citicoline (Cognizin) 500 mg/d or 250 mg/d vs placebo for 12 weeks in healthy older adults aged 50-85 y, with computerized cognitive assessment.
Key Findings
Citicoline supplementation improved overall memory performance, particularly episodic memory, relative to placebo in healthy older adults.
Conclusions
Citicoline supplementation for 12 weeks improved memory function in cognitively healthy older adults.
Limitations
Industry-sponsored by the citicoline manufacturer; modest sample size; healthy population limits generalisation to clinical cognitive impairment.
Supplements Studied
Citicoline supplementation for 12 weeks improved memory function in cognitively healthy older adults.
Outcomes Measured
Citicoline supplementation for 12 weeks improved memory function in cognitively healthy older adults.
Citicoline supplementation for 12 weeks improved memory function in cognitively healthy older adults.
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Kyowa Hakko Bio Co., Ltd (manufacturer)
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.